Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Loxo Oncology, Inc. | 3,796,362 | reported | 11 Dec 2015 | tx 5+3,263,986−2,850,709 |
| Durata Therapeutics, Inc. | 0 | reported | 20 May 2014 | tx 2−749,258 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Dec 2015 | PURCHASE | Loxo Oncology, Inc. | 200 | 27.50 USD | first after silence |
| 06 Aug 2014 | PURCHASE | Loxo Oncology, Inc. | 413,077 | 13.00 USD | |
| 06 Aug 2014 | CONVERSION | Loxo Oncology, Inc. | 2,850,709 | 0.00 USD | |
| 06 Aug 2014 | CONVERSION | Loxo Oncology, Inc. | 2,343,749 | 0.00 USD | deriv |
| 06 Aug 2014 | CONVERSION | Loxo Oncology, Inc. | 506,960 | 0.00 USD | deriv |
| 20 May 2014 | OTHER | Durata Therapeutics, Inc. | 745,730 | 0.00 USD | |
| 20 May 2014 | OTHER | Durata Therapeutics, Inc. | 3,528 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 11 Dec 2015.